Healthcare Cryoport (CYRX) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect 1 month ago Ticker: CYRX | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Cryoport, the specialized cold chain logistics… Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect 1 month ago Ticker: RIGL | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Rigel Pharmaceuticals, a specialty pharma company… Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 month ago Zymeworks Inc. (NASDAQ: ZYME), a Canada-based clinical-stage biotechnology company, on Monday reported a wider net loss for the fourth quarter… Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 month ago Smith+Nephew (NYSE: SNN) reported revenue growth across its operating segments for the fourth quarter of fiscal 2025. The medical technology… Sleep Tech Demand Fuels ResMed 2 months ago Executive Summary ResMed has transitioned from a cyclical medical device manufacturer into a structurally growing digital health platform anchored in… BrightSpring Health Services Q4 FY25 earnings jump on strong revenue growth 2 months ago BrightSpring Health Services, Inc. (NASDAQ: BTSG), a provider of home and community-based health services, on Friday reported a sharp increase… Agilent Q1 Revenue Rises 7%, Net Income Declines 2 months ago Agilent Technologies Reports Mixed 1Q 2026 Financial Results An analysis of recent data released via infographic on Agilent Technologies, Inc.… UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story 2 months ago UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story Important takeaways from Medtronic’s (MDT) Q3 2026 earnings report 2 months ago Shares of Medtronic Plc (NYSE: MDT) declined this week, despite the company reporting stronger-than-expected Q3 2026 earnings. Investors were unsettled… Pulse Biosciences Shares Fall After Q4 Loss Widens as Clinical Spending Rises and Revenue Remains Limited 2 months ago Shares of Pulse Biosciences Inc. (Nasdaq: PLSE) were down about 2% in afternoon trading on Thursday after the company reported… Next» « Previous